Elizabeth Mittendorf: Profound Honor to Begin My Term as 2026-27 ASCO President
Oncology's Greatest Threat: A System in Crisis
Roche–Nurix $2.3 Billion Deal for BTK Degrader Bexobrutideg in Blood Cancers
ESMO Updates Metastatic Breast Cancer Guideline: A More Molecular, Subtype-Driven Roadmap For Care
Integrating Targeted Therapies into HMA-Venetoclax in AML: Perspectives from ASCO 2026
Muna Al-Khaifi: Redefining Survivorship Care - Key Lessons from ASCO 2026
Bridging the Gap Between Clinical Practice and Holistic, Patient-Centred Care - ESO
15 Posts Not To Miss From ASCO 2026: GU Edition
